Clinical trial
An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder
NCT02161159 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder
- Lead sponsor
- Allergan
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2014
- Completion date
- January 31, 2016
- Enrollment
- 515 (actual)
- Sites
- 54
Conditions
As the registry lists them; a condition with its own page is linked.